In which patients is succinylcholine contraindicated because of risk of hyperkalemia, and how should hyperkalemia be managed if it occurs?

Succinylcholine and Hyperkalemia

Succinylcholine is absolutely contraindicated in patients with upregulation of nicotinic acetylcholine receptors (burns >24-48 hours old, denervation injuries, prolonged immobilization, upper motor neuron lesions) and primary muscle diseases (myopathies, muscular dystrophy), as it can cause fatal hyperkalemia and cardiac arrest. 1

High-Risk Contraindications for Succinylcholine

Absolute Contraindications (Life-Threatening Hyperkalemia Risk)

Primary muscle damage:

• Myopathies (including Duchenne muscular dystrophy)
• Myotonia
• Known or suspected malignant hyperthermia history 2, 1

Nicotinic receptor upregulation conditions (risk peaks 7-10 days post-injury and persists for weeks to months):

• Major burns after the acute phase (>24-48 hours post-injury) 1
• Extensive denervation of skeletal muscle 2, 1
• Upper motor neuron injury (spinal cord injuries, stroke with paralysis) 2, 1, 3
• Multiple trauma with extensive tissue damage 1
• Prolonged immobilization (>16 days in ICU carries 37% risk of K+ ≥6.5 mmol/L) 4
• Chronic abdominal infection 1

Relative Contraindications (Use with GREAT CAUTION per FDA)

• Pre-existing hyperkalemia or electrolyte abnormalities 1
• Acute renal failure or chronic kidney disease 5
• Massive digitalis toxicity 1
• Sepsis with prolonged ICU stay 6
• Neuromuscular diseases (multiple sclerosis, myasthenia gravis) 7
• Patients on beta-blockers (propranolol) - potential additive hyperkalemic effect 8

Critical Timing Considerations

The most dangerous period is 7-10 days post-injury for trauma, burns, or denervation, though the exact onset and duration remain undefined. Research demonstrates that ICU stay >16 days dramatically increases hyperkalemia risk (37% vs 1% for stays <16 days) 4. Even patients who previously tolerated succinylcholine safely can develop life-threatening hyperkalemia with repeat administration after developing risk factors 9.

Management of Succinylcholine-Induced Hyperkalemia

If cardiac arrest or severe arrhythmia occurs:

1. Immediate cardiac resuscitation - CPR and defibrillation as needed 6

2. Membrane stabilization (FIRST priority):

   • Calcium chloride 10% 10-20 mL IV push (or calcium gluconate 30 mL) - acts within 1-3 minutes 6

3. Shift potassium intracellularly:

   • Sodium bicarbonate 50-100 mEq IV 9, 6
   • Regular insulin 10 units IV with 50 mL dextrose 50% 9, 6
   • Hyperventilation to induce respiratory alkalosis 9

4. Supportive measures:

   • Antiarrhythmics (lidocaine, atropine for bradycardia) as needed 6
   • Continuous cardiac monitoring 1

The hyperkalemia typically resolves within 30 minutes with aggressive treatment 6, but the key is immediate recognition and intervention.

Safer Alternative

Rocuronium 0.9-1.2 mg/kg is the preferred alternative in high-risk patients 2. Recent evidence shows no significant difference in adverse outcomes between rocuronium and succinylcholine even in patients with pre-existing hyperkalemia (K+ >5.5 mmol/L), with 24-hour mortality of 10% for both agents 10. However, this study's findings should not encourage succinylcholine use in patients with established contraindications - rather, it suggests rocuronium is safe when succinylcholine would be dangerous.

Critical Pitfalls to Avoid

• Never assume prior safe use guarantees future safety - patients can develop contraindications between administrations 9
• ICU patients have exceptionally high contraindication prevalence (71% of ICU patient-days have at least one contraindication) 5
• The normal 0.5-1.0 mEq/L potassium rise becomes 3-5+ mEq/L in susceptible patients - enough to cause immediate cardiac arrest 1, 6
• Pediatric patients require higher doses but face the same hyperkalemia risks in susceptible conditions 2